Growth Metrics

bioAffinity Technologies (BIAF) Income from Continuing Operations (2022 - 2025)

Historic Income from Continuing Operations for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to -$5.1 million.

  • bioAffinity Technologies' Income from Continuing Operations fell 15244.82% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.7 million, marking a year-over-year decrease of 7450.88%. This contributed to the annual value of -$9.0 million for FY2024, which is 1389.47% down from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Income from Continuing Operations is -$5.1 million, which was down 15244.82% from -$4.1 million recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Income from Continuing Operations ranged from a high of -$88052.0 in Q2 2022 and a low of -$5.1 million during Q3 2025
  • Over the past 4 years, bioAffinity Technologies' median Income from Continuing Operations value was -$2.1 million (recorded in 2024), while the average stood at -$2.5 million.
  • Examining YoY changes over the last 5 years, bioAffinity Technologies' Income from Continuing Operations showed a top increase of 5343.22% in 2023 and a maximum decrease of 187630.15% in 2023.
  • bioAffinity Technologies' Income from Continuing Operations (Quarter) stood at -$1.7 million in 2022, then crashed by 41.72% to -$2.4 million in 2023, then decreased by 25.02% to -$3.0 million in 2024, then tumbled by 70.25% to -$5.1 million in 2025.
  • Its last three reported values are -$5.1 million in Q3 2025, -$4.1 million for Q2 2025, and -$2.7 million during Q1 2025.